Vencanna VenturesVENCF +80.00% EV-to-FCF is 1.01 as of Jun. 24, 2026. The stock has 4 warning signs investors should review. Among 562 Drug Manufacturers companies, Vencanna Ventures ranks better than 96.98% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Vencanna Ventures's Enterprise Value is $-0.53 Mil.
Vencanna Ventures's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.53 Mil. Therefore, Vencanna Ventures's EV-to-FCF for today is 1.01.
The historical rank and industry rank for Vencanna Ventures's EV-to-FCF or its related term are showing as below:
VENCF'
s EV-to-FCF Range Over the Past 10 Years
Min: -2.99 Med: -1.4 Max: 1
Current: 0.98
During the past 13 years, the highest EV-to-FCF of Vencanna Ventures was 1.00. The lowest was -2.99. And the median was -1.40.
VENCF's EV-to-FCF is ranked better than 96.98% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.11
vs VENCF: 0.98
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vencanna Ventures's PE Ratio (TTM) for today is calculated as:
Vencanna Ventures's share price for today is $0.001.
Vencanna Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Vencanna Ventures EV-to-FCF Related Terms
Vencanna Ventures EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Vencanna Ventures's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vencanna Ventures EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Vencanna Ventures's EV-to-FCF falls into.
Vencanna Ventures's current Enterprise Value is $-0.53 Mil.
Vencanna Ventures's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vencanna Ventures (VENCF) has a EV-to-FCF of 1.01 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Vencanna Ventures and its competitors. According to the industry distribution chart, Vencanna Ventures ranks #17 out of 562 companies in the Drug Manufacturers industry, placing it in the top 3%.
Is Vencanna Ventures' EV-to-FCF too high?
Vencanna Ventures' current EV-to-FCF is 1.01. The Drug Manufacturers industry median EV-to-FCF is 20.11. Vencanna Ventures' value of 1.01 is 95% below this industry median. Based on the distribution chart, Vencanna Ventures ranks #17 out of 562 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Vencanna Ventures' EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #17 out of 562 companies for EV-to-FCF. This places Vencanna Ventures in the top 3% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 20.11. Vencanna Ventures' value of 1.01 is 95% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.11, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vencanna Ventures's current EV-to-FCF of 1.01 is 95% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current EV-to-FCF is 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current EV-to-FCF of 1.01. The current EV-to-FCF is 1.01 and 95% below the Drug Manufacturers industry median of 20.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current EV-to-FCF is 1.01 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VENCF has been successfully added to your 